KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Assets (2016 - 2025)

Bausch Health Companies' Assets history spans 17 years, with the latest figure at $26.4 billion for Q4 2025.

  • For Q4 2025, Assets fell 0.59% year-over-year to $26.4 billion; the TTM value through Dec 2025 reached $26.4 billion, down 0.59%, while the annual FY2025 figure was $26.4 billion, 0.59% down from the prior year.
  • Assets for Q4 2025 was $26.4 billion at Bausch Health Companies, down from $26.8 billion in the prior quarter.
  • Across five years, Assets topped out at $30.2 billion in Q1 2021 and bottomed at $25.4 billion in Q1 2023.
  • The 5-year median for Assets is $26.9 billion (2024), against an average of $27.3 billion.
  • The largest annual shift saw Assets surged 77328.21% in 2021 before it decreased 12.53% in 2023.
  • A 5-year view of Assets shows it stood at $29.2 billion in 2021, then decreased by 12.04% to $25.7 billion in 2022, then grew by 6.48% to $27.4 billion in 2023, then dropped by 3.02% to $26.5 billion in 2024, then decreased by 0.59% to $26.4 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Assets are $26.4 billion (Q4 2025), $26.8 billion (Q3 2025), and $27.3 billion (Q2 2025).